Literature DB >> 15680437

Smallpox vaccines: from first to second to third generation.

Gregory A Poland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15680437     DOI： 10.1016/S0140-6736(05)17840-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.

Authors:  George W Buchman; Matthew E Cohen; Yuhong Xiao; Nicola Richardson-Harman; Peter Silvera; Louis J DeTolla; Heather L Davis; Roselyn J Eisenberg; Gary H Cohen; Stuart N Isaacs
Journal:  Vaccine       Date:  2010-07-24       Impact factor: 3.641

2.  The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Authors:  Richard B Kennedy; Gregory A Poland
Journal:  Virology       Date:  2010-10-18       Impact factor: 3.616

3.  Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine.

Authors:  Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2011-06-01       Impact factor: 5.226

Review 4.  Smallpox vaccines for biodefense.

Authors:  Richard B Kennedy; Inna Ovsyannikova; Gregory A Poland
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

5.  Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.

Authors:  Stephen R Walsh; Jacqueline Gillis; Björn Peters; Bianca R Mothé; John Sidney; Alessandro Sette; R Paul Johnson
Journal:  Vaccine       Date:  2009-06-14       Impact factor: 3.641

6.  Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay.

Authors:  Richard Kennedy; V Shane Pankratz; Eric Swanson; David Watson; Hana Golding; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

7.  Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpox.

Authors:  Qiang Liu; Changfa Fan; Shuya Zhou; Yanan Guo; Qin Zuo; Jian Ma; Susu Liu; Xi Wu; Zexu Peng; Tao Fan; Chaoshe Guo; Yuelei Shen; Weijin Huang; Baowen Li; Zhengming He; Youchun Wang
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

8.  Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.

Authors:  Massimiliano Bissa; Sole Maria Pacchioni; Carlo Zanotto; Carlo De Giuli Morghen; Elena Illiano; Francesca Granucci; Ivan Zanoni; Achille Broggi; Antonia Radaelli
Journal:  Virus Res       Date:  2013-09-16       Impact factor: 6.286

9.  Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity.

Authors:  Massimiliano Bissa; Elena Quaglino; Carlo Zanotto; Elena Illiano; Valeria Rolih; Sole Pacchioni; Federica Cavallo; Carlo De Giuli Morghen; Antonia Radaelli
Journal:  Antiviral Res       Date:  2016-09-13       Impact factor: 10.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.